Vir Biotechnology Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -95.1% | -94.7% | +183.3% | +405.9% | +175.6% | +313.5% | +483.5% | +1,059.0% | -99.7% | +60.1% | +101.0% | +29,167.4% | -41.5% | +684.4% | +51.6% | -103.3% | – | -86.8% | +27.4% | -94.0% | -30.5% | +536.1% | +235.8% | -94.5% | -22.6% | +419.9% | -75.5% | -60.0% | -80.2% | +26,595.8% | -100.0% | – | – | |
| – | +0.0% | +28.6% | -20.2% | +8.6% | +15.2% | +33.7% | +34.8% | +7.6% | +37.8% | -11.3% | -99.6% | +44,718.8% | -35.3% | +22.0% | +73.9% | -2.6% | -20.7% | -4.6% | +18.1% | -1.0% | +5.4% | -13.7% | -26.7% | -7.4% | +6.7% | +85.6% | -54.5% | +32.5% | -17.1% | +55.3% | -342.0% | – | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -99.7% | +60.1% | +101.0% | +14,742.6% | -103.2% | – | +67.7% | -117.5% | – | -146.9% | – | – | – | – | – | – | – | – | – | – | – | – | -100.7% | – | – | |
| – | +0.0% | +23.2% | -26.4% | +17.7% | +15.2% | +33.7% | +32.8% | +22.8% | +22.6% | -11.3% | +23.2% | +54.9% | -36.1% | +14.6% | +30.1% | -29.7% | +27.5% | -0.8% | +35.9% | +1.6% | +6.6% | -13.7% | -24.9% | -8.1% | +5.0% | +85.7% | -45.6% | +11.8% | -17.8% | +55.3% | -41.7% | +23.3% | +24.2% | – | |
| – | +0.0% | +7.3% | +7.5% | +7.7% | -6.4% | +15.1% | +28.1% | +7.1% | +29.5% | +15.1% | +22.2% | +11.7% | +11.8% | +75.4% | -49.0% | +48.6% | +8.7% | +3.8% | -10.3% | +20.7% | +0.7% | -12.8% | +4.9% | -15.8% | -16.6% | -14.9% | +3.7% | -10.3% | -6.9% | -0.2% | +6.2% | -1.2% | +29.4% | – | |
| – | +0.0% | +330.5% | -22.2% | +14.9% | +16.5% | +33.6% | -77.1% | +80.3% | +381.1% | -7.9% | +23.8% | +46.5% | -81.9% | +75.4% | +10.5% | -31.4% | +8.7% | +3.8% | -10.3% | +20.7% | +8.8% | -12.9% | +11.6% | -23.3% | +49.1% | -32.0% | +5.9% | -38.7% | -11.4% | +0.5% | +2,001.8% | -72.1% | +27.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -187.5% | – | +77.3% | -122.2% | – | -177.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +5,026.0% | -53.1% | +4.2% | -97.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +79.0% | +392.8% | +68.9% | -125.4% | – | -169.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -11,325.0% | – | -168.4% | – | -89.3% | +187.5% | -52.2% | -236.4% | – | -73.0% | +530.2% | +6,078.1% | +1,854.4% | -139.0% | – | -218.0% | – | – | – | – | – | -647.8% | – | -148.6% | – | +962.5% | -1.2% | -181.5% | – | +5.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +78.6% | +375.7% | -1.3% | -114.7% | – | -158.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +77.0% | +445.8% | +50.7% | -125.1% | – | -168.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.